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Introduction: Limited procedures at the T4 ganglion show low rates of compensatory sweating (CS). The
aim of the study was to compare endoscopic sympathetic block (ESB) via clip application with endo-
thoracic sympathicotomy (ETS) via diathermy with special regard on patients' quality of life (Qol). Pa-
tients and methods: Treatment success, side effects and patient satisfaction were evaluated in a
prospectively gathered database of a tertiary-care referral hospital. Two disease-speciﬁc Qol question-
naires were used (Keller, Milanez de Campos). Results: 406 operations were performed in 205 patients
(ESB4 N ¼ 114, ETS4 N ¼ 91) with a median follow-up of 12 months. Both procedures improved Qol
signiﬁcantly (P < 0.001) and the degree of improvement was equal in both groups. Palmar and axillary
HH were ameliorated after both procedures (P < 0.001). Accordingly, plantar HH decreased after ESB4
(P ¼ 0.002), while remaining unaltered after ETS4. Nineteen patients (9.3%) reported CS and 10 patients
(4.9%) judged it as “disturbing”. Nine of the latter belonged to the ETS4 group compared to one ESB
patient (P ¼ 0.015). Patients developed higher rates of plantar CS after ETS4 compared to ESB4
(P ¼ 0.006). Five patients (2.4%) from both cohorts reported persistence of axillary HH. Recurrence of
axillary symptoms was found in 5 ESB4 patients. Satisfaction rates did not differ signiﬁcantly. Conclu-
sion: Patients' Qol and satisfaction rates are similar in both treatment groups for upper limb HH.
Outcome and recurrence rates speak in the favor of ETS4, severity of CS and potential reversibility argue
for ESB4.
© 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Sympathetic surgery is the treatment of choice for severe pri-
mary hyperhidrosis (HH), a pathological condition of excessive, University Clinic of Surgery,
-20, Vienna A-1090, Austria.
(P. Panhofer).
by Elsevier Ltd. All rights reservedsweating, most frequently affecting palms and armpits [1,2].
Recurrent social embarrassment dramatically impairs patients'
quality of life (Qol) [3,4]. Today, endothoracic sympathetic surgery
can be provided with excellent long-term results and low
morbidity rates [1,4,5]. Moreover, this surgical procedure also im-
proves patients' Qol impressively [3,4,6].
Compensatory sweating (CS) is the most common side effect
and the main reason for dissatisfaction and impaired Qol after.
Table 1
Demographic data.
Characteristics Overall (n ¼ 205) ESB4a (n ¼ 114) ETS4b (n ¼ 91)
Female 146 (71.2%) 83 (72.8%) 63 (69.2%)
Agec 28 (24e36) 28 (24e36) 27 (23e36)
BMI kg/m2c 22 (20e24) 22 (20e24) 22 (21e25)
Positive family history 108 (52.7%) 59 (51.8%) 49 (53.8%)
HHd since childhood 102 (49.8%) 72 (63.2%) 30 (33.0%)
HH since adolescence 78 (38.0%) 34 (29.8%) 44 (48.3%)
HH after adolescence 25 (12.2%) 8 (7.0%) 17 (18.7%)
Emotional trigger 132 (64.4%) 76 (66.7%) 56 (61.5%)
Physical trigger 96 (46.8%) 56 (49.1%) 40 (44.0%)
Heat trigger 114 (55.6%) 67 (58.8%) 47 (51.6%)
Isolated palmar HH 37 (18.0%) 31 (27.2%) 6 (6.6%)
Isolated axillary HH 37 (18.0%) 17 (14.9%) 20 (22.0%)
Combined palmoaxillary HH 131 (63.9%) 66 (57.9%) 65 (71.4%)
Plantar HH 133 (64.9%) 86 (75.4%) 47 (51.6%)
Procedures 406 227 179
Follow-upc 12 (12e14) 12 (12e13) 13 (12e15)
a Endothoracic Sympathetic Block by clips at T4.
b Endoscopic Thoracic Sympathicotomy by diathermy at T4.
c Data are medians with interquartile range in parentheses.
d Hyperhidrosis.
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been recommended, as several reports indicated the frequency and
severity of CS to be correlated with the number of ablated ganglia
[7e11]. Another approach to reduce CS was LineTelaranta's hy-
pothesis. They recommended sparing the T2 and T3 ganglia for
upper limb HH [12]. In fact, limited T4 procedures showed lower
rates of CS than T3 or T2 procedures [7,13e15], although the debate
on this topic is ongoing [16,17].
Comparisons of different surgical techniques are rare, especially
between those applied at the same level of the sympathetic trunk
[18e21]. In particular, only few investigations compared outcome
and side effects of sympathicotomies versus clip application
[18e21]. Data are available on limited T2 [19] and T3 [20] pro-
cedures, as well as combined T3eT4 techniques [21]. However, a
report on limited T4 procedures is still lacking. Moreover, none of
these reports included patients' Qol analyses.
The aim of our study was to compare limited procedures at the
T4 ganglion for primary upper-limb HH. The outcome analysis
involved effects and side effects as well as patients' satisfaction.
Special emphasis was laid on evaluation of patients' disease speciﬁc
Qol comparing endothoracic sympathetic blocks at T4 (ESB4) via
clip application with endoscopic thoracic sympathicotomies at T4
(ETS4).
2. Patients and methods
2.1. Study design
All patients having undergone sympathetic surgery for upper
limb HH, were registered in a prospective database. Patients gave
their informed consent prior to surgery. The study was approved by
the local Ethics Committee (EK-Nr. 405/2011). It was conducted
according to the criteria of Good Clinical Practice, as edited by the
Medical University of Vienna and the Declaration of Helsinki of
1964, updated in Seoul 2008.
2.2. Surgery
The procedure of ESB4 has previously been reported in detail
[22]. The ﬁrst visible and/or palpable rib was regarded as the 2nd
rib. Accordingly, the corresponding ganglion was identiﬁed as the
2nd ganglion. The 4th thoracic ganglion was usually found below
the 4th rib or just above the 5th rib. In the ESB4 group a 5-mm
reusable clip applier (Challenger Ti; B. Braun, Maria Enzersdorf,
Austria) was used to block the sympathetic trunk above and below
the 4th sympathetic ganglion. Likewise, the sympathetic trunk was
severed above and below the 4th ganglion by a diathermic hook
(Electrocautery 3.5 mm; Richard Wolf GmbH, Kittlingen, Germany)
in the ETS4 group. All operative procedures were performed by
three surgeons (Manfred Prager, Georg Bischof, Christoph Neu-
mayer) in the same standardized manner. All of them had been
equally trained at the University Clinic of Surgery in the Medical
University of Vienna. Generally, patients were discharged from the
hospital on the ﬁrst or second day post-surgery.
2.3. Outcome
Two evaluative and disease-speciﬁc Qol questionnaires, the
Keller Hyperhidrosis scale and the Milanez de Campos Qol ques-
tionnaire, were used to assess the extent of HH and Qol before and
after ESB4 and ETS4, respectively. Both questionnaires reﬂect
common physical symptoms and social stigmata associated with
primary sweating in everyday life [24,25], and have been described
in detail in a previous study [3].Preoperative extent of HH and postoperative treatment success
were evaluated on a scale from 0 (no sweating) to 10 (most severe
sweating). Hands, armpits and feet valued with 0e2 points were
deﬁned as dry. Improvement of HH was obtained when post-
operative scores were lower than preoperative ones. Persistence of
HH was reported when postoperative scores were unchanged or
higher than preoperative ones.
Likewise, the major side effects of sympathetic surgery such as
compensatory sweating (CS) and gustatory sweating were inves-
tigated. CS was deﬁned as increased postoperative sweating in
other regions than armpits and hands. Both side effects were
graded as “not affecting”, “barely affecting” or “disturbing”.
In addition, patients' satisfaction was assessed as complete or
partial satisfaction or as dissatisfaction [7,22,23].2.4. Follow-up
Information was obtained by physical examination, personal
interviews and interrogative telephone calls. Data were collected
preoperatively and 1 year after operation using a standardized
protocol. Patients presenting with problems such as disturbing CS
or recurrences visited the outpatient ward and had another phys-
ical examination and personal interview.2.5. Statistical analyses
Continuous data are described using median and quartiles due
to their skewed distribution. Categorical variables are described by
absolute and relative frequencies. Pre-post differences were
compared between groups using multi-variable analysis of
covariance (ANCOVA) models in order to adjust for baseline group
differences with respect to sex, age (log-transformed), body mass
index (log-transformed), type of HH (palmar/axillary/combined)
and baseline value of the considered outcome variable. Balanced
model least squares means with 95% conﬁdence intervals are re-
ported for each group, i.e. least squares means were estimated at
marginal means of the covariates (i.e. irrespective of group). Binary
outcomes (e.g., CS yes/no) were compared between groups using
logistic regression models. Due to the low number of events, only
the most important baseline variable sex was used for adjustment
und Firth's correction was used to deal with separation problems
[26]. The reported p values are the results of two-sided tests.
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outcomewas Qol. No correction for multiple testing was performed
due to the exploratory character of the study with respect to sec-
ondary outcome. All computations were done applying SAS soft-
ware version 9.3 (SAS Institute Inc., Cary, NC, USA, 2010).3. Results
Out of 205 patients, clip application was used in 114 patients
(55.6%) at the Departments of Surgery, Medical University, and the
St. Josef Hospital of Vienna. 91 patients underwent sympathicomies
at the Department of Surgery, Oberwart Hospital. Bilateral ESB4
was performed in 113 patients (99.1%) and bilateral ETS4 in 88
patients (96.7%). The majority of patients underwent extensive
conservative therapy before being referred to surgery. De-
mographic data and patients' characteristics are shown in Table 1.3.1. Complications
Overall, 13 complications (6.3%) were reported. There were no
major perioperative complications (such as Horner syndrome), and
conversion to open surgerywas not necessary. Three patients in the
ESB4 group (2.6%) and in the ETS4 group (3.3%) each required chest
tube drainage due to unilateral pneumothorax (>3 cm). In the ESB4
group, three subcutaneous emphysemas (2.6%) occurred and 2
venous bleedings (1.8%), which could be treated intraoperatively by
additional clip application. In the ETS4 group, two patients (2.2%)
suffered from postoperative neuralgia and were sufﬁciently treated
with non-steroidal analgesics.3.2. Treatment success
In general, treatment of upper limbs was successful in both
cohorts (pre-versus postoperative HH: palmar HH: P < 0.001,
axillary HH: P < 0.001). On contrary, treatment effect on lower
limbs was different in both procedures. Patients from the ESB4
group experienced improved postoperative lower limb sweating
(pre-versus postoperative HH: plantar HH: P ¼ 0.001) while ETS4
patients did not report signiﬁcant relief (preoperative versus
postoperative HH: plantar HH: P ¼ 0.615).Fig. 1. Treatment success (values: 0e10) at the main sweating localisations in patients
undergoing Endoscopic Sympathetic Block by clipping (ESB4) and Endoscopic Thoracic
Sympathicotomy by diathermy (ETS4). Dryness: postoperative score2. Improvement:
postoperative < preoperative score and postoperative score >2. Persistence: post-
operative preoperative score and postoperative score >2. Data are presented as
percentages.In particular, treatment success, deﬁned as dryness and
improvement of sweating, was achieved in 100% of patients with
palmar HH. Treatment success in the armpits, however, was slightly
higher after ETS4 (97.7%) compared to ESB4 (92.8%). In turn,
improvement of plantar HH was detected in 45.3% of ESB4 patients
as compared to 14.9% of ETS4 patients. Data are presented in Fig. 1.
Treatment success of upper limb HH was similar in ESB4 and
ETS4 (ESB4 versus ETS4: palmar HH: P ¼ 0.440; axillary HH:
P ¼ 0.155). In contrast, lower limb HH was positively inﬂuenced in
the ESB4 group (ESB4 versus ETS4: P¼ 0.010). Preoperative data are
given in Table 2 and postoperative success rates are shown in Fig. 2.
3.3. Side effects
Nineteen patients (9.3%), including 9 ESB4 (7.9%) and 10 ETS4
(11.0%) patients, developed CS after surgical treatment (ESB4 versus
ETS4: P ¼ 0.479) (Table 3). Ten out of 19 patients (52.6%) graded CS
as “disturbing”. Out of them, all but one ETS4 patient (9/91: 9.9%)
complained about disturbing CS as compared to merely one patient
(1/114: 0.9%) in the ESB4 group (P ¼ 0.015; OR [95% CI] ¼ 8.46
[1.52e47.3]).
72 patients (72/205: 35.1%) had not suffered from plantar HH
before surgical treatment. Out of that group, one patient (1/28:
3.6%) in the ESB4 group and 14 ETS patients (14/44: 31.8%) devel-
oped CS of the feet postoperatively (ESB4 versus ETS4: P ¼ 0.006).
Gustatory sweating was reported in less than 10% of patients. It
was signiﬁcantly more frequent (P ¼ 0.010) in the ESB4 group (16/
114: 14.0%) than among ETS4 patients (3/91: 3.3%). Nevertheless,
none of these patients felt disturbed by the latter side effect.
3.4. Recurrence
Ten patients (4.9%) reported persistence or recurrence of
symptoms. Persistence of axillary HH was detected in 5 patients
(2.4%), including 3 ESB4 (3/114: 2.6%) and 2 ETS4 patients (2/91:
2.2%). None of them underwent surgical reintervention during 12
months of follow-up.
Recurrences were found in another 5 patients after ESB4. All
patients were reoperated and an additional clip was placed above
the third ganglion. Two patients regained dry limbs, whereas 3
patients reported a mere improvement of symptoms.
3.5. Satisfaction
Overall, the great majority of patients were satisﬁed with the
postoperative outcome. There was no difference between the
treatment groups (P ¼ 0.299). Complete (ESB4: 86.0% versus ETS4:Table 2
Preoperative data.
Patients Extent of
hyperhidrosisc
Quality of life
Keller scorec Milanez de
Camposc
Palmar manifestation
ESB4a 97 (85.1%) 10 (9e10) 8.2 (6.7e10.0) 4.1 (3.6e4.5)
ETS4b 71 (78.0%) 8 (7e10) 4.4 (2.2e7.1) 3.2 (2.7e3.8)
Axillary manifestation
ESB4 83 (72.8%) 10 (8e10) 10.0 (8.0e10.0) 3.9 (3.1e4.5)
ETS4 85 (93.4%) 10 (8e10) 10.0 (8.0e10.0) 3.0 (2.5e3.5)
Plantar manifestation
ESB4 86 (75.4%) 8 (6e10) 7.4 (5.0e9.0) 4.0 (3.5e4.5)
ETS4 47 (51.6%) 10 (8e10) 10.0 (8.0e10.0) 3.5 (2.6e4.0)
a Endothoracic Sympathetic Block by clips at T4.
b Endoscopic Thoracic Sympathicotomy by diathermy at T4.
c Data are medians with interquartile range in parentheses.
Fig. 2. Treatment success (values: 0e10) and quality of life using the Keller score
(values: 0e10) and the Milanez de Campos questionnaire (values: 1e5) of palmar,
axillary and plantar hyperhidrosis in patients treated with Endothoracic Sympathetic
Block by clips at T4 (ESB4) or Endoscopic Thoracic Sympathicotomy by diathermy at T4
(ETS4). Error bars show balanced model least squares means and 95% conﬁdence
intervals.
Table 3
Side effects.
Side effects ESB4a (n ¼ 114) ETS4b (n ¼ 91)
“Disturbing”/
Overall
“Disturbing”/
Overall
Compensatory sweating 1/9 (11.1%) 9/10 (90%)
Head 0/0 (0%) 5/5 (100%)
Chest 1/1 (100%) 4/4 (100%)
Abdomen 0/3 (0%) 5/5 (100%)
Back 1/7 (14.3%) 3/3 (100%)
Legs 1/3 (33.3%) 3/3 (100%)
Feet 0/1 (0%) 5/5 (100%)
Other 0/1 (0%) 2/3 (66.7%)
Gustatory sweating 0/16 (0%) 0/3 (0%)
a Endothoracic Sympathetic Block by clips at T4.
b Endoscopic Thoracic Sympathicotomy by diathermy at T4.
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11.0%) were similar in both cohorts. Out of 3 dissatisﬁed patients (3/
205: 1.5%), one ESB4 patient (1/114: 0.9%) suffered from insufﬁcient
relief of axillary HH. In the ETS4 group, 2 patients (2/91: 2.2%) were
dissatisﬁed on account of disturbing CS. All but 6 patients (6/205:
2.9%) with palmoaxillary HH would recommend the operation
(ESB4: 98.3% versus ETS4: 95.6%). There was no difference between
the two cohorts. Reasons for decline were recurrence, persistence
and disturbing CS.3.6. Quality of life
In all patients, sympathetic surgery signiﬁcantly improved
disease-speciﬁc Qol. Qol analysis showed a signiﬁcant improve-
ment of upper limb HH in both groups (Milanez de Campos: pre-
versus postoperative Qol: ESB4: P < 0.001 and ETS4: P < 0.001).
In particular, palmar and axillary sweating diminished post-
operatively in both cohorts (Keller: pre-versus postoperative Qol:ESB4: P < 0.001 and ETS4: P < 0.001). Postoperative Qol of patients
suffering from plantar HH signiﬁcantly improved in the ESB4 group
(Keller: pre-versus postoperative Qol: P ¼ 0.002), while remaining
unaltered in the ETS4 cohort (Keller: pre-versus postoperative Qol:
P ¼ 0.199).
Qol improvement was equal in both groups (Milanez de Cam-
pos: ESB4 versus ETS4: P ¼ 0.241). Likewise, Keller scores did not
differ signiﬁcantly neither for upper limb HH (Keller: ESB4 versus
ETS4: palmar HH: P ¼ 0.695; axillary HH: P ¼ 0.155) nor for lower
limb HH (Keller: ESB4 versus ETS4: plantar HH: P ¼ 0.127). Data are
presented in Fig. 2.
4. Discussion
Awide spectrum of techniques has been evolved in sympathetic
surgery to minimize side effects and to achieve optimal outcomes.
Limited procedures at T4 show low rates of CS, the most disturbing
side effect after sympathetic surgery [7,16,27]. To the best of our
knowledge, the current study is the ﬁrst investigation of disease-
speciﬁc Qol, comparing two different surgical procedures at the
same level of the T4 ganglion.
Upper limb HH improved primely in both groups, with higher
rates of dry palms in the ETS4 group, although not signiﬁcant.
Similar results were published at the level of T2 and T3 [18e20].
Postoperative outcomes of axillary HH were slightly worse as
compared to palmar HH. This ﬁnding is in line with a recent expert
consensus and our own results [4,15]. The major reason for
impaired axillary outcome is that armpits contain eccrine and
apocrine sweat glands. The latter are merely affected by epineph-
rine, whereas eccrine glands respond to sympathectomy [28].
Consequently, sympathetic surgery is less effective in patients with
axillary HH [4]. Axillary symptom relief was higher following ETS4
as compared to ESB4, yet not signiﬁcantly. Similar results have been
reported for T2, T3 and combined T3eT4 procedures comparing
diathermic cut with clip application [18e21].
Improvement of plantar HH was observed in nearly 50% of ESB4
patients as compared to less than 15% in the ETS4 cohort. Actually,
endothoracic sympathetic surgery is no primary treatment option
for lower limb HH. Instead, lumbar sympathectomy, in experienced
hands, yields excellent results for this indication [29,30]. Never-
theless, several authors reported improvement of plantar HH after
endothoracic procedures. This may be explained, at least hypo-
thetically, by the immense variations of the sympathetic ﬁbers
along with their multiple interganglionic connections [31,32].
Alleviation of plantar HH varied between 43% and 63% in the
literature, with better outcomes after clip application [18,20,22].
Compensatory sweating rates were low in our study compared to
the literature. This may be attributed to our deﬁnition of CS, at least
in part. Chou and coworkers emphasized that sweating in a hot
climate or during exercise should be considered as physiologic [13].
Consequently, physiologically altered sweating was not graded as
CS. Therefore, in our study CS was deﬁned as increased sweating
without trigger. In the present investigation CS was classiﬁed as
“disturbing” in about 5% as compared to 4%e19% in the literature
[4,19e21,33e35]. Patients in the ETS4 cohort were affected more
frequently, especially in the feet. Reisfeld et al. also reported
signiﬁcantly lower levels of severe CS after ESB [19], whereas other
investigations did not reach statistical signiﬁcance [20,21]. CS of the
feet is another major issue, as many patients with upper limb HH
also suffer from lower limb HH. In a former investigation from our
clinic, up to one third of patients developed plantar CS after ETS
[36]. Later on, we were able to report on CS of the feet in less than
6% of patients after ESB4 [22]. The results of the present investi-
gation conﬁrm those previous data. During ETS procedures,
diathermic damage of collateral sympathetic ﬁbers may cause a
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more invasive ETS procedures aggravate postoperative CS.
Overall, persistence and recurrence of HH reached 5% and are
comparable with 3%e23% in the literature [14,21,37]. Persistence of
HH solely affected the armpits as did recurrences in all but one
patient. Nevertheless, none of the patients with persistent HH
underwent surgical re-intervention within the follow-up period. In
our opinion, the potential loss of efﬁcacy over time may be a major
problem associated with limited ESB4. However, results on this
topic are controversial. Coelho et al. [21] reported insufﬁcient relief
in approximately 20% for both procedures, whereas Reisfeld et al.
[19] indicated signiﬁcantly lower recurrence rates after ESB as
compared to ETS. Finally, the number of ablated ganglia and the
invasiveness of the surgical intervention correlate with the rates of
dryness [7] and recurrences on the one hand [4,33,36]. On the other
hand the severity of CS increases with extensive tissue damage.
[19,20]
In our study, patients' satisfaction rates were high in both
groups. However, less than 2% of patients were dissatisﬁed due to
persistence or recurrence of HH and/or CS. Satisfaction rates range
from 93% to 98% in the literature. In smaller study cohorts statistical
signiﬁcance was not identiﬁed when comparing ESB with ETS
procedures [18,20,21]. On the contrary, one large series with more
than 1300 patients reported signiﬁcantly higher satisfaction rates
in the ESB versus the ETS cohort [19]. Accordingly, recommenda-
tions of this surgical technique were more frequent after ESB pro-
cedures [19,20]. This may be explained by the observation that
patients prefer procedures which are less destructive and have the
potential of reversibility. [19]
The primary outcome of this investigation was disease-speciﬁc
Qol. In general, sympathetic surgery is known to offer excellent
symptom relief [3,4]. Qol integrates the inﬂuence of symptom re-
lief, recurrence rates and CS and helps to compare two cohorts with
each other. In the present investigation Qol improved signiﬁcantly
after sympathetic surgery, which parallels previous studies [3,4,20].
Milanez de Campos' questionnaires provide disease-speciﬁc infor-
mation on sweating under various situations of daily life. Keller's
Qol scales focus on the different sites of primary HH. Consequently,
both questionnaires cover the problem of primary HH abundantly.
Postoperative Qol was equivalent, when comparing both cohorts.
Positive effects of low CS rates may be antagonized by higher
amounts of recurrences in the ESB4 group. Most publications pre-
sent satisfaction rates [5,7,10], although Qol evaluation is more
disease-speciﬁc [4,6,25]. In our opinion both, satisfaction rates and
Qol scores should be included as standard evaluation for HH
assessment.
A methodological limitation of the present study is that each
participating center offered only one of the two methods
compared. Using multi-variable models, the estimated effects were
therefore adjusted for the most important baseline differences.
In conclusion, patients' Qol and satisfaction rates are similar in
both treatment groups for upper limb HH. ETS4 yields effective
denervation of the sympathetic trunk with slightly better outcome
on armpits and presented no recurrences after one year follow-up.
ESB4, however, is of advantage for patients with plantar HH and
causes less disturbing CS. In addition, ESB4 provides potential
reversibility. In case of severe recurrent HH, re-operations with
additional clip application are a viable and easy solution.
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